Fecal calprotectin: A selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy

References

• Rubin GP, Hungin AP, Kelly PJ, Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000;14:1553–9.
   PubMed Web of Science ®Google Scholar
• Tibble JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001;7:460–5.
   PubMed Web of Science ®Google Scholar
• Van Limbergen J, Russell RK, Nimmo ER, Satsangi J. The genetics of inflammatory bowel disease. Am J Gastroenterol 2007;102:2820–31.
   PubMed Web of Science ®Google Scholar
• Roth LS, Chande N, Ponich T, Roth ML, Gregor J. Predictors of disease severity in ulcerative colitis patients from Southwestern Ontario. World J Gastroenterol 2010;16:232–6.
   PubMedGoogle Scholar
• Triester SL, Leighton JA, Leontiadis GI, A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with nonstricturing small bowel Crohn's disease. Am J Gastroenterol 2006;101:954–64.
   PubMed Web of Science ®Google Scholar
• Dionisio PM, Gurudu SR, Leighton JA, Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn's disease: a meta-analysis. Am J Gastroenterol 2010;105:1240–8.
   PubMed Web of Science ®Google Scholar
• Ge ZZ, Hu YB, Xiao SD. Capsule endoscopy in diagnosis of small bowel Crohn's disease. World J Gastroenterol 2004;10:1349–52.
   PubMed Web of Science ®Google Scholar
• Bourreille A, Ignjatovic A, Aabakken L, World Organisation of Digestive Endoscopy (OMED) and the European Crohn's and Colitis Organisation (ECCO). Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy 2009;41:618–37.
   PubMed Web of Science ®Google Scholar
• Lasson A, Kilander A, Stotzer PO. Diagnostic yield of colonoscopy based on symptoms. Scand J Gastroenterol 2008;43:356–62.
   PubMed Web of Science ®Google Scholar
• Lewis BS, Eisen GM, Friedman S. A pooled analysis to evaluate results of capsule endoscopy trials. Endoscopy 2005;37:960–5.
   PubMed Web of Science ®Google Scholar
• Doherty GA, Moss AC, Cheifetz AS. Capsule endoscopy in suspected Crohn's disease: “yield” does not equal “diagnosis”. Am J Gastroenterol 2010;105:2111.
   PubMedGoogle Scholar
• Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis 2009;41:56–66.
   PubMedGoogle Scholar
• Johne B, Kronborg O, Ton HI, Fuglerud P. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Scand J Gastroenterol 2001;36:291–6.
   PubMed Web of Science ®Google Scholar
• Tibble JA, Sigthorsson G, Foster R, High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362–6.
   PubMed Web of Science ®Google Scholar
• von Roon AC, Karamountzos L, Purkayastha S, Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007;102:803–13.
   PubMed Web of Science ®Google Scholar
• van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.
   PubMed Web of Science ®Google Scholar
• Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 2004;20:615–21.
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Defranchis R, Seidman E, Leighton JA, Legnani P, Lewis BS. Development of a capsule endoscopyscoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008;27:146–54.
   PubMed Web of Science ®Google Scholar
• Fagerhol MK, Dale I, Andersson T. A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull Eur Physiopathol Respir 1980;16(Suppl):273–82.
   PubMedGoogle Scholar
• Desai D, Faubion WA, Sandborn WJ. Review article: biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther 2007;25:247–55.
   PubMed Web of Science ®Google Scholar
• Bjerke K, Halstensen TS, Jahnsen F, Pulford K, Brandtzaeg P. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human. Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 1993;34:1357–63.
   PubMed Web of Science ®Google Scholar
• Jahnsen J, Roseth AG, Aadland E. Measurement of calprotectin in faeces [Article in Norwegian]. Tidsskr Nor Laegeforen 2009;129:743–5.
   PubMedGoogle Scholar
• Logan R. Faecal calprotectin for the diagnosis of inflammatory bowel disease. BMJ 2010;341:c3636.
   Google Scholar
• Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:50–4.
   PubMed Web of Science ®Google Scholar
• Poullis A, Irwin AG, Dearing M, Repeat planar white cell scanning to monitor short-term therapy of active inflammatory bowel disease: a methodological study and comparison with clinical scores and novel inflammatory markers. Eur J Gastroenterol Hepatol 2006;18:607–14.
   PubMedGoogle Scholar
• Tibble JA, Sigthorsson G, Bridger S, Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15–22.
   PubMed Web of Science ®Google Scholar
• Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMNelastase, CRP and clinical indices. Am J Gastroenterol 2008;103:162–9.
   PubMed Web of Science ®Google Scholar